ARTG 371752CoolSculpting Elite - Cryolipolysis skin contouring system
ARTG ID: 371752 · Abbvie Pty Ltd · Zeltiq Aesthetics Inc · Class IIa · Started July 28, 2021
Good Name: Abbvie Pty Ltd - CoolSculpting Elite - Cryolipolysis skin contouring system
- Risk Class
- Class IIa
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 371752
- Start Date
- July 28, 2021
- Effective Date
- July 28, 2021
- Name
- Abbvie Pty Ltd
- Country
- United States of America
- Address
- 4410 Rosewood Drive , Pleasanton, CA, 94588
The COOLSCULPTING® ELITE System is a non-invasive cooling device that applies controlled cooling to a treatment site on the patient’s skin. The device is intended to be used for the following medical purposes: * Fat layer reduction through cold-assisted lipolysis to reduce localised areas of fat * Skin cooling as a local anaesthetic for procedures that induce minor local discomfort * Minimising pain and thermal injury during laser and dermatological treatments. The device is not intended to cause weight loss or to treat obesity.
Access comprehensive regulatory information for CoolSculpting Elite - Cryolipolysis skin contouring system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 371752 and sponsored by Abbvie Pty Ltd, manufactured by Zeltiq Aesthetics Inc in United States of America. The device registration started on July 28, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.